Zapi SpA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zapi SpA - overview
Established
1975
Location
-, -, Italy
Primary Industry
Electronics
About
Zapi S. p. A. is a prominent Italian company engaged in the research, development, and production of effective rodenticides and insecticides designed to safeguard various environments from pest infestations.
Founded in 1975 in Italy, Zapi S. p. A. specializes in pest control solutions and has expanded its operations globally.
The company has not undergone any significant pivots or changes in its core business strategy. Zapi is not known to have any subsidiaries or parent companies. The founder's specific history is not documented, and there is no mention of prior ventures. Zapi has successfully raised funds through various rounds, with the most recent funding amounting to EUR 35.
03 mn in 2023. Zapi S. p. A.
specializes in the research, development, and production of rodenticides and insecticides aimed at protecting household, industrial, and rural environments from pest infestations. The company offers innovative and cost-effective solutions that encompass a full-service approach, which includes biocide authorization, product formulation, packaging development, and delivery to target markets. Their core product offerings are categorized under two primary brands: Zapi Garden, which provides over 200 products specifically for home protection against rats, mice, and insects, as well as green care solutions like agrochemicals and fertilizers; and Protemax, which was established in 2018, focusing on pest control products distributed through DIY, hardware, and mass market channels. Zapi's clientele includes both individual consumers and retailers across multiple markets, with a presence in over 60 countries worldwide, ensuring effective pest management solutions for both domestic and professional users.
In 2023, Zapi S. p. A. reported a revenue of EUR 35.
03 mn and an EBITDA of EUR 2. 28 mn. The company operates through a structured business model that includes both direct sales and partnerships with retailers and wholesalers. Revenue is generated primarily from the sale of flagship products under the Zapi Garden and Protemax brands, distributed through various channels, including specialized stores and mass markets.
This approach incorporates direct-to-consumer sales and B2B relationships, allowing for flexible pricing strategies tailored to different market needs. Zapi S. p. A.
is focused on introducing new products designed to enhance its pest control offerings, although no specific release dates are available. The company aims to expand into new geographic markets, particularly in Asia and Eastern Europe, with plans to establish operations by 2025. Recent funding will be utilized to support product development and market entry initiatives, enhancing Zapi's capacity to meet the evolving demands of pest management solutions.
Primary Industry
Electronics
Sub Industries
Automobiles, Other Vehicles & Parts, Electronic Components
Website
www.zapispa.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Zapi SpA - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Delta-Q Technologies Corp. | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.